{
    "clinical_study": {
        "@rank": "6766", 
        "brief_summary": {
            "textblock": "RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing\n      so they stop growing or die.\n\n      PURPOSE: Phase II trial to study the effectiveness of temozolomide in treating patients with\n      recurrent oligodendroglial tumors following combination chemotherapy."
        }, 
        "brief_title": "Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors", 
        "condition": "Brain and Central Nervous System Tumors", 
        "condition_browse": {
            "mesh_term": [
                "Nervous System Neoplasms", 
                "Central Nervous System Neoplasms"
            ]
        }, 
        "detailed_description": {
            "textblock": "OBJECTIVES: I. Determine the response rate and duration of response in oligodendroglial\n      tumors to temozolomide treatment in patients with progressive disease during or after\n      procarbazine/lomustine/vincristine (PCV) chemotherapy. II. Determine the feasibility and\n      toxicity of temozolomide chemotherapy following PVC chemotherapy in these patients.\n\n      OUTLINE: This is an open label, multicenter trial. Temozolomide is administered orally on\n      days 1-5 of each 4-week course; treatment continues for a maximum of 12 courses. Patients\n      are followed every 2 months for the first 6 months and then every 3 months thereafter.\n\n      PROJECTED ACCRUAL: A total of 16-29 patients will be accrued for this study."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "DISEASE CHARACTERISTICS: Histologically proven oligodendroglioma or oligoastrocytoma (with\n        at least 25% oligodendroglial elements) Recurrent or progressive disease following both\n        radiotherapy and procarbazine/lomustine/vincristine chemotherapy (or other\n        nitrosoureas-based chemotherapy) Contrast enhancing, measurable disease (at least one\n        lesion measuring at least 1 cm) by CT or MRI required Within 2 weeks prior to study\n        treatment Within 3 days following concurrent surgery for the recurrence Steroid doses\n        stable or decreasing for at least 2 weeks prior to scan No extracranial disease\n\n        PATIENT CHARACTERISTICS: Age: 18-69 Performance status: WHO 0-2 Life expectancy: At least\n        3 months Hematopoietic: Absolute neutrophil count at least 1,500/mm3 Platelet count at\n        least 100,000/mm3 Hepatic: Bilirubin no greater than 1.25 times upper limit of normal\n        (ULN) Alkaline phosphatase no greater than 2 times ULN AST/ALT no greater than 2 times ULN\n        Renal: Creatinine no greater than 1.25 times ULN Creatinine clearance at least 60 mL/min\n        Other: Not pregnant or lactating Effective contraception required of fertile women No\n        diseases interfering with follow-up\n\n        PRIOR CONCURRENT THERAPY: Biologic therapy: Not specified Chemotherapy: See Disease\n        Characteristics No more than one prior chemotherapy regimen At least 4 weeks since prior\n        chemotherapy Prior nitrosourea required At least 6 weeks since nitrosourea Endocrine\n        therapy: Not specified Radiotherapy: See Disease Characteristics More than 3 months since\n        radiotherapy Surgery: Not specified Other: No concurrent treatment with other\n        investigational agents or other antitumor agents"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "69 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "29", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 1, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00003304", 
            "org_study_id": "EORTC-26972", 
            "secondary_id": "EORTC-26972"
        }, 
        "intervention": {
            "intervention_name": "temozolomide", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Temozolomide", 
                "Dacarbazine"
            ]
        }, 
        "keyword": "adult oligodendroglioma", 
        "lastchanged_date": "March 5, 2012", 
        "link": {
            "description": "Clinical trial summary from the National Cancer Institute's PDQ\u00ae database", 
            "url": "http://cancer.gov/clinicaltrials/EORTC-26972"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Vienna (Wien)", 
                        "country": "Austria", 
                        "zip": "A-1100"
                    }, 
                    "name": "Kaiser Franz Josef Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brussels", 
                        "country": "Belgium", 
                        "zip": "1070"
                    }, 
                    "name": "Hopital Universitaire Erasme"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Copenhagen", 
                        "country": "Denmark", 
                        "zip": "2100"
                    }, 
                    "name": "Rigshospitalet"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Helsinki", 
                        "country": "Finland", 
                        "zip": "FIN-0-0029"
                    }, 
                    "name": "Helsinki University Central Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Turku", 
                        "country": "Finland", 
                        "zip": "FIN-2-0521"
                    }, 
                    "name": "Turku University Central Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bordeaux", 
                        "country": "France", 
                        "zip": "33076"
                    }, 
                    "name": "Institut Bergonie"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Caen", 
                        "country": "France", 
                        "zip": "14076"
                    }, 
                    "name": "Centre Regional Francois Baclesse"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Colmar", 
                        "country": "France", 
                        "zip": "68024"
                    }, 
                    "name": "Hopital Louis Pasteur"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Le Kremlin Bicetre", 
                        "country": "France", 
                        "zip": "94275"
                    }, 
                    "name": "Centre Hospitalier Universitaire de Bicetre"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lyon", 
                        "country": "France", 
                        "zip": "69373"
                    }, 
                    "name": "Centre Leon Berard"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Marseille", 
                        "country": "France", 
                        "zip": "13385"
                    }, 
                    "name": "CHU de la Timone"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nancy", 
                        "country": "France", 
                        "zip": "54035"
                    }, 
                    "name": "CHU de Nancy - Hopital Neurologique"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nantes-Saint Herblain", 
                        "country": "France", 
                        "zip": "44805"
                    }, 
                    "name": "CRLCC Nantes - Atlantique"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nice", 
                        "country": "France", 
                        "zip": "06189"
                    }, 
                    "name": "Centre Antoine Lacassagne"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nice", 
                        "country": "France", 
                        "zip": "06002"
                    }, 
                    "name": "Hopital Pasteur"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nimes", 
                        "country": "France", 
                        "zip": "30000"
                    }, 
                    "name": "C.H.R. de Nimes - Hopital Caremeau"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75651"
                    }, 
                    "name": "CHU Pitie-Salpetriere"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Villejuif", 
                        "country": "France", 
                        "zip": "F-94805"
                    }, 
                    "name": "Institut Gustave Roussy"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany", 
                        "zip": "D-12200"
                    }, 
                    "name": "Universitaetsklinikum Benjamin Franklin"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hannover", 
                        "country": "Germany", 
                        "zip": "D-30559"
                    }, 
                    "name": "Neurologische Klinik der Henriettenstiftung"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tuebingen", 
                        "country": "Germany", 
                        "zip": "D-72076"
                    }, 
                    "name": "Universitaetsklinikum Tuebingen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Budapest", 
                        "country": "Hungary", 
                        "zip": "1145"
                    }, 
                    "name": "National Institute of Neurosurgery"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Padova (Padua)", 
                        "country": "Italy", 
                        "zip": "35128"
                    }, 
                    "name": "Azienda Ospedaliera di Padova"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Torino", 
                        "country": "Italy", 
                        "zip": "10126"
                    }, 
                    "name": "Universita Degli Studi di Torino"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Amsterdam", 
                        "country": "Netherlands", 
                        "zip": "1007 MB"
                    }, 
                    "name": "Academisch Ziekenhuis der Vrije Universiteit"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Amsterdam", 
                        "country": "Netherlands", 
                        "zip": "1066 CX"
                    }, 
                    "name": "Antoni van Leeuwenhoekhuis"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Groningen", 
                        "country": "Netherlands", 
                        "zip": "9713 EZ"
                    }, 
                    "name": "Academisch Ziekenhuis Groningen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Maastricht", 
                        "country": "Netherlands", 
                        "zip": "6202 AZ"
                    }, 
                    "name": "Academisch Ziekenhuis Maastricht"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nijmegen", 
                        "country": "Netherlands", 
                        "zip": "6500 HB"
                    }, 
                    "name": "St. Radboud University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rotterdam", 
                        "country": "Netherlands", 
                        "zip": "3075 EA"
                    }, 
                    "name": "Rotterdam Cancer Institute"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tilburg", 
                        "country": "Netherlands", 
                        "zip": "5042 SB"
                    }, 
                    "name": "Dr. Bernard Verbeeten Instituut"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tilburg", 
                        "country": "Netherlands", 
                        "zip": "5022 GC"
                    }, 
                    "name": "St. Elisabeth Ziekenhuis"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Utrecht", 
                        "country": "Netherlands", 
                        "zip": "3508 GA"
                    }, 
                    "name": "Academisch Ziekenhuis Utrecht"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lisbon", 
                        "country": "Portugal", 
                        "zip": "1093"
                    }, 
                    "name": "Instituto Portugues de Oncologia de Francisco Gentil"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Umea", 
                        "country": "Sweden", 
                        "zip": "S-901 85"
                    }, 
                    "name": "Umea Universitet"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Edinburgh", 
                        "country": "United Kingdom", 
                        "state": "Scotland", 
                        "zip": "EH4 9NQ"
                    }, 
                    "name": "Western General Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Glasgow", 
                        "country": "United Kingdom", 
                        "state": "Scotland", 
                        "zip": "G11 6NT"
                    }, 
                    "name": "Beatson Oncology Centre"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "Austria", 
                "Belgium", 
                "Denmark", 
                "Finland", 
                "France", 
                "Germany", 
                "Hungary", 
                "Italy", 
                "Netherlands", 
                "Portugal", 
                "Sweden", 
                "United Kingdom"
            ]
        }, 
        "official_title": "Second Line Chemotherapy With Temozolomide in Recurrent Oligodendroglial Tumors After PCV-Chemotherapy", 
        "overall_official": {
            "affiliation": "Daniel Den Hoed Cancer Center at Erasmus Medical Center", 
            "last_name": "Martin J. van Den Bent, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "March 2000", 
            "@type": "Actual"
        }, 
        "reference": {
            "PMID": "16914310", 
            "citation": "Kouwenhoven MC, Kros JM, French PJ, Biemond-ter Stege EM, Graveland WJ, Taphoorn MJ, Brandes AA, van den Bent MJ. 1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment. Eur J Cancer. 2006 Oct;42(15):2499-503. Epub 2006 Aug 17."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00003304"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "results_reference": {
            "PMID": "12649108", 
            "citation": "van den Bent MJ, Chinot O, Boogerd W, Bravo Marques J, Taphoorn MJ, Kros JM, van der Rijt CC, Vecht CJ, De Beule N, Baron B. Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972. Ann Oncol. 2003 Apr;14(4):599-602."
        }, 
        "source": "European Organisation for Research and Treatment of Cancer - EORTC", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "European Organisation for Research and Treatment of Cancer - EORTC", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 1998", 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2012"
    }, 
    "geocoordinates": {
        "Academisch Ziekenhuis Groningen": "53.219 6.567", 
        "Academisch Ziekenhuis Maastricht": "50.851 5.691", 
        "Academisch Ziekenhuis Utrecht": "52.09 5.11", 
        "Academisch Ziekenhuis der Vrije Universiteit": "52.37 4.895", 
        "Antoni van Leeuwenhoekhuis": "52.37 4.895", 
        "Azienda Ospedaliera di Padova": "45.41 11.877", 
        "Beatson Oncology Centre": "55.864 -4.252", 
        "C.H.R. de Nimes - Hopital Caremeau": "43.837 4.36", 
        "CHU Pitie-Salpetriere": "48.857 2.352", 
        "CHU de Nancy - Hopital Neurologique": "48.692 6.184", 
        "CHU de la Timone": "43.296 5.37", 
        "CRLCC Nantes - Atlantique": "47.21 -1.602", 
        "Centre Antoine Lacassagne": "43.696 7.266", 
        "Centre Hospitalier Universitaire de Bicetre": "48.81 2.357", 
        "Centre Leon Berard": "45.764 4.836", 
        "Centre Regional Francois Baclesse": "49.183 -0.371", 
        "Dr. Bernard Verbeeten Instituut": "51.586 5.079", 
        "Helsinki University Central Hospital": "60.17 24.939", 
        "Hopital Louis Pasteur": "48.079 7.359", 
        "Hopital Pasteur": "43.696 7.266", 
        "Hopital Universitaire Erasme": "50.85 4.352", 
        "Institut Bergonie": "44.838 -0.579", 
        "Institut Gustave Roussy": "48.793 2.359", 
        "Instituto Portugues de Oncologia de Francisco Gentil": "38.707 -9.136", 
        "Kaiser Franz Josef Hospital": "48.208 16.374", 
        "National Institute of Neurosurgery": "47.498 19.041", 
        "Neurologische Klinik der Henriettenstiftung": "52.384 9.727", 
        "Rigshospitalet": "55.676 12.568", 
        "Rotterdam Cancer Institute": "51.924 4.482", 
        "St. Elisabeth Ziekenhuis": "51.586 5.079", 
        "St. Radboud University Hospital": "51.843 5.855", 
        "Turku University Central Hospital": "60.449 22.259", 
        "Umea Universitet": "63.826 20.263", 
        "Universita Degli Studi di Torino": "45.071 7.684", 
        "Universitaetsklinikum Benjamin Franklin": "52.524 13.406", 
        "Universitaetsklinikum Tuebingen": "48.521 9.059", 
        "Western General Hospital": "55.953 -3.188"
    }
}